A listing of Linda DiMeglio, MD medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
What is the purpose of this study?This study is the long-term extension of the PRV-031-001 (PROTECT) study. PROTECT is a Phase 3, randomized, double-blind, placebo-controlled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, anti-CD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently …
RationaleThe accrual of data from the laboratory and from epidemiologic and prevention trials hasved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, andharacterization of the early metabolic abnormalities in T1DM is steadily …
Researchers are looking for volunteers between 8-45 years of age who have been recently diagnosed with Type 1 diabetes mellitus (T1DM)ke part in a study identify a safe, metabolically favorable, dosing regimen of a treatment called siplizumab that targets the immune response and missing beta cell function that leads to …
The purpose of the recruitment database is to store information on people who might be eligible to participate in current or future diabetes research studies.
The purpose of this research study is to measure how much of the study drug (Afrezza) gets into your bloodafter a single dose and measure how well it works to control your blood sugar level. We also want to make surethis study drug is safe for children and adolescents between …
